search
Back to results

Rudi Kundini, Pamoja Kundini (RKPK: Phase II)

Primary Purpose

HIV (Human Immunodeficiency Virus)

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
PKC (adapted adherence counseling) and Conditional Cash Transfers
Sponsored by
University of California, Berkeley
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for HIV (Human Immunodeficiency Virus) focused on measuring Tanzania, Conditional Cash Transfers, People Living With HIV, Machine Learning

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • PLHIV on ART who have had a visit in the last 90 days and a viral load in the last 6 months;
  • Age 18 years or older;
  • Phone ownership OR consistent phone access;
  • Living in Geita or Kagera Regions and intends to receive care at a study facility for the next 12 months;
  • Classified as "high-risk" for LTFU from HIV care, and
  • Provides written informed consent for participation

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Adapted Adherence Counseling (PKC) and Conditional Cash Transfers

    Enhanced Adherence Counseling only for those who qualify

    Arm Description

    Eligible and consenting participants randomized to the intervention arm will receive the same standard HIV clinical services according Tanzania's National Guidelines for the Management of HIV as the comparison arm, which includes provision of three, once-monthly, 60-minute nurse-led individual, enhanced adherence counseling sessions adapted for study purposes (PKC sessions). Counseling focuses on the meaning of viral loads and supportive, non-judgmental strategies for adherence and visit attendance. A minimum of three sessions are required. In addition to enhanced adherence counseling, intervention participants will receive the offer of a cash transfer paired with attendance at each of the three enhanced adherence counseling sessions. The first payment will occur at enrollment; the next two cash transfers are payable upon visit attendance and attendance of the two remaining enhanced adherence counseling sessions.

    Eligible and consenting participants randomized to the control arm will receive standard of care HIV clinical services according to Tanzania's National Guidelines for the Management of HIV. For those who meet clinic eligibility criteria for enhanced adherence counseling, this includes the standard provision of three, once-monthly, 60-minute nurse-led individual, enhanced adherence counseling sessions, starting on the day of a detectable viral load result and for two months after. Counseling focuses on the meaning of viral loads and supportive, non-judgmental strategies for adherence and visit attendance. A minimum of three sessions are required.

    Outcomes

    Primary Outcome Measures

    12-Month Viral Suppression
    The proportion of people living with HIV (PLHIV) and on ART with suppressed HIV viral load ( <1000 copies/ml) at 12 months after study enrollment.

    Secondary Outcome Measures

    6-month retention in care
    The proportion of people living with HIV (PLHIV) on ART at 6 months after study enrollment (PEPFAR considers those not retained on ART to include those who died, disengaged from care, stopped ART, or had no evidence of care for ≥28 days after a missed visit. Participants not found after exhaustive tracing efforts to rule out silent transfers will be classified as not retained on ART)
    12-month retention in care
    The proportion of people living with HIV (PLHIV) on ART at 12 months after study enrollment (PEPFAR considers those not retained on ART to include those who died, disengaged from care, stopped ART, or had no evidence of care for ≥28 days after a missed visit. Participants not found after exhaustive tracing efforts to rule out silent transfers will be classified as not retained on ART)
    12-month durable viral load
    Proportion with durable HIV viral suppression 12 months after enrollment: at least 2 viral load measurements taken from up to 6 months prior to study enrollment and up to and including 12 months following study enrollment and all are undetectable (<1000 copies/ml) will have met criteria for durable viral suppression at 12 months.
    12-month Appointment Attendance
    The proportion of scheduled visits that were completed during the 0-12 month period
    6-month Appointment Attendance
    The proportion of scheduled visits that were completed during the 0-6 month period
    12-month Mortality
    The cumulative incidence of mortality at 12 months after study enrollment
    6-month Predictive value positive (PVP) of machine learning algorithm
    Predictive value positive (PVP) of the machine learning algorithm in identifying PLHIV at-risk of disengagement from HIV care within 6 months
    12-month Predictive value positive (PVP) of machine learning algorithm
    Predictive value positive (PVP) of the machine learning algorithm in identifying PLHIV at-risk of disengagement from HIV care within 12 months
    6-month PVP of routine clinical criteria
    PVP of the routine clinical criteria (i.e. recent missed visit or detectable viral load, >1000 copies/ml) for identifying PLHIV at-risk of disengagement from HIV care within 6 months
    12-month PVP of routine clinical criteria
    PVP of the routine clinical criteria (i.e. recent missed visit or detectable viral load, >1000 copies/ml) for identifying PLHIV at-risk of disengagement from HIV care within 12 months
    6-month Predictive value negative (PVN) of the machine learning algorithm
    Predictive value negative (PVN) of the machine learning algorithm in identifying PLHIV not at-risk of disengagement from HIV care within 6 months
    12-month PVN of the machine learning algorithm
    PVN of the machine learning algorithm in identifying PLHIV not at-risk of disengagement from HIV care within 12 months
    6-month PVN of routine clinical criteria
    PVN of the routine clinical criteria for identifying PLHIV not at-risk of disengagement from HIV care within 6 months
    12-month PVN of routine clinical criteria
    PVN of the routine clinical criteria for identifying PLHIV not at-risk of disengagement from HIV care within 12 months
    Enhanced Adherence Counseling Session Attendance
    Proportion of enhanced adherence counseling sessions completed among sessions scheduled
    Viral Suppression with enhanced adherence counseling completion
    Proportion with HIV viral suppression after completion of enhanced adherence counseling sessions

    Full Information

    First Posted
    May 9, 2022
    Last Updated
    May 24, 2023
    Sponsor
    University of California, Berkeley
    Collaborators
    Health for a Prosperous Nation, Rasello, Management and Development for Health, Ministry of Health, Tanzania, National Institute of Mental Health (NIMH)
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05373095
    Brief Title
    Rudi Kundini, Pamoja Kundini
    Acronym
    RKPK: Phase II
    Official Title
    Strengthening the Continuity of HIV Care in Tanzania With Economic Support: Phase II
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    June 2023 (Anticipated)
    Primary Completion Date
    January 2024 (Anticipated)
    Study Completion Date
    January 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University of California, Berkeley
    Collaborators
    Health for a Prosperous Nation, Rasello, Management and Development for Health, Ministry of Health, Tanzania, National Institute of Mental Health (NIMH)

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    This protocol describes an individually randomized trial that will include adult people living with HIV (PLHIV) currently receiving HIV care at one of two participating health facilities and identified as high risk for disengagement from care by a machine learning algorithm. Participants randomized to the control arm will receive standard of care HIV clinical services according to Tanzania's National Guidelines for the management of HIV. For those who meet clinic eligibility criteria for enhanced adherence counseling, which at the included study sites is when client's viral load reaches a detectable level (>1000 copies/ml), this includes the standard provision of three, once-monthly, 60-minute nurse-led individual, enhanced adherence counseling sessions, starting on the day of the result and for two months after. Intervention arm participants will receive the same standard HIV care services plus the offer of a cash transfer paired with visit attendance and attendance at each of the three adapted enhanced adherence counseling sessions (referred to as PKC sessions).
    Detailed Description
    This protocol describes a 2-armed parallel individually randomized controlled trial for which 692 PLHIV who meet eligibility criteria, are currently accessing care at one of two participating health facilities (Katoro Health Facility and Geita Regional Referral Hospital), and have provided informed consent to be part of the study will be randomized in a 1:1 ratio (n=346 PLHIV in each arm), stratified by site, to the control or intervention group. We will use machine learning to finalize a predictive model based on routinely collected medical and pharmacy record data to identify and recruit PLHIV for participation at Geita Regional Referral Hospital and Katoro Health Facility who are at high-risk for disengaging from HIV care. Eligible and consenting participants randomized to the control arm will receive standard of care HIV clinical services according to Tanzania's National Guidelines for the Management of HIV. Criteria for enrollment into enhanced adherence counseling sessions at Katoro Health Facility and Geita Regional Referral Hospitals includes when client's viral load reaches a detectable level (>1000 copies/ml). Enhanced adherence counseling includes the standard provision of three, once-monthly, 60-minute nurse-led individual, enhanced adherence counseling sessions, starting on the day of the result and for two months after. Counseling focuses on the meaning of viral loads and supportive, non-judgmental strategies for adherence and visit attendance. At Geita Regional Referral Hospital, sessions are conducted in an individual, 1:1 setting with a trained counselor who is on the clinical staff. At Katoro Health Facility, sessions are conducted either in a group or in an individual, 1:1 setting with a trained counselor who is on the clinical staff. A minimum of three sessions are required. Eligible and consenting participants randomized to the intervention arm will receive the same standard HIV care services plus the offer of a cash transfer paired with visit attendance and attendance at each of the three adapted enhanced adherence counseling sessions (PKC sessions). The first payment will occur at enrollment; the next two cash transfers are payable upon visit attendance and attendance of the two remaining enhanced adherence counseling sessions. Due to the nature of the intervention, participants will not be blinded to intervention assignment. The primary endpoint is durable viral load suppression (<1000 copies/ml) at 12 months following study enrollment.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    HIV (Human Immunodeficiency Virus)
    Keywords
    Tanzania, Conditional Cash Transfers, People Living With HIV, Machine Learning

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Masking Description
    Laboratory staff analyzing viral load samples will be blind to intervention/control attribution.
    Allocation
    Randomized
    Enrollment
    692 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Adapted Adherence Counseling (PKC) and Conditional Cash Transfers
    Arm Type
    Experimental
    Arm Description
    Eligible and consenting participants randomized to the intervention arm will receive the same standard HIV clinical services according Tanzania's National Guidelines for the Management of HIV as the comparison arm, which includes provision of three, once-monthly, 60-minute nurse-led individual, enhanced adherence counseling sessions adapted for study purposes (PKC sessions). Counseling focuses on the meaning of viral loads and supportive, non-judgmental strategies for adherence and visit attendance. A minimum of three sessions are required. In addition to enhanced adherence counseling, intervention participants will receive the offer of a cash transfer paired with attendance at each of the three enhanced adherence counseling sessions. The first payment will occur at enrollment; the next two cash transfers are payable upon visit attendance and attendance of the two remaining enhanced adherence counseling sessions.
    Arm Title
    Enhanced Adherence Counseling only for those who qualify
    Arm Type
    No Intervention
    Arm Description
    Eligible and consenting participants randomized to the control arm will receive standard of care HIV clinical services according to Tanzania's National Guidelines for the Management of HIV. For those who meet clinic eligibility criteria for enhanced adherence counseling, this includes the standard provision of three, once-monthly, 60-minute nurse-led individual, enhanced adherence counseling sessions, starting on the day of a detectable viral load result and for two months after. Counseling focuses on the meaning of viral loads and supportive, non-judgmental strategies for adherence and visit attendance. A minimum of three sessions are required.
    Intervention Type
    Behavioral
    Intervention Name(s)
    PKC (adapted adherence counseling) and Conditional Cash Transfers
    Intervention Description
    The intervention includes up to 3 cash transfers of 22,500 Tanzanian Shillings (~$10) paired with attendance at each of the three adapted enhanced adherence counseling sessions (PKC sessions). The first cash transfer will occur at enrollment; the next two cash transfers are payable upon visit attendance and attendance of the two remaining PKC sessions. The cash transfers will include extra funds for transaction fees, typically <$1.
    Primary Outcome Measure Information:
    Title
    12-Month Viral Suppression
    Description
    The proportion of people living with HIV (PLHIV) and on ART with suppressed HIV viral load ( <1000 copies/ml) at 12 months after study enrollment.
    Time Frame
    12 months
    Secondary Outcome Measure Information:
    Title
    6-month retention in care
    Description
    The proportion of people living with HIV (PLHIV) on ART at 6 months after study enrollment (PEPFAR considers those not retained on ART to include those who died, disengaged from care, stopped ART, or had no evidence of care for ≥28 days after a missed visit. Participants not found after exhaustive tracing efforts to rule out silent transfers will be classified as not retained on ART)
    Time Frame
    6 months
    Title
    12-month retention in care
    Description
    The proportion of people living with HIV (PLHIV) on ART at 12 months after study enrollment (PEPFAR considers those not retained on ART to include those who died, disengaged from care, stopped ART, or had no evidence of care for ≥28 days after a missed visit. Participants not found after exhaustive tracing efforts to rule out silent transfers will be classified as not retained on ART)
    Time Frame
    12 months
    Title
    12-month durable viral load
    Description
    Proportion with durable HIV viral suppression 12 months after enrollment: at least 2 viral load measurements taken from up to 6 months prior to study enrollment and up to and including 12 months following study enrollment and all are undetectable (<1000 copies/ml) will have met criteria for durable viral suppression at 12 months.
    Time Frame
    12 months
    Title
    12-month Appointment Attendance
    Description
    The proportion of scheduled visits that were completed during the 0-12 month period
    Time Frame
    12 months
    Title
    6-month Appointment Attendance
    Description
    The proportion of scheduled visits that were completed during the 0-6 month period
    Time Frame
    6 months
    Title
    12-month Mortality
    Description
    The cumulative incidence of mortality at 12 months after study enrollment
    Time Frame
    12 months
    Title
    6-month Predictive value positive (PVP) of machine learning algorithm
    Description
    Predictive value positive (PVP) of the machine learning algorithm in identifying PLHIV at-risk of disengagement from HIV care within 6 months
    Time Frame
    6 months
    Title
    12-month Predictive value positive (PVP) of machine learning algorithm
    Description
    Predictive value positive (PVP) of the machine learning algorithm in identifying PLHIV at-risk of disengagement from HIV care within 12 months
    Time Frame
    12 months
    Title
    6-month PVP of routine clinical criteria
    Description
    PVP of the routine clinical criteria (i.e. recent missed visit or detectable viral load, >1000 copies/ml) for identifying PLHIV at-risk of disengagement from HIV care within 6 months
    Time Frame
    6 months
    Title
    12-month PVP of routine clinical criteria
    Description
    PVP of the routine clinical criteria (i.e. recent missed visit or detectable viral load, >1000 copies/ml) for identifying PLHIV at-risk of disengagement from HIV care within 12 months
    Time Frame
    12 months
    Title
    6-month Predictive value negative (PVN) of the machine learning algorithm
    Description
    Predictive value negative (PVN) of the machine learning algorithm in identifying PLHIV not at-risk of disengagement from HIV care within 6 months
    Time Frame
    6 months
    Title
    12-month PVN of the machine learning algorithm
    Description
    PVN of the machine learning algorithm in identifying PLHIV not at-risk of disengagement from HIV care within 12 months
    Time Frame
    12 months
    Title
    6-month PVN of routine clinical criteria
    Description
    PVN of the routine clinical criteria for identifying PLHIV not at-risk of disengagement from HIV care within 6 months
    Time Frame
    6 months
    Title
    12-month PVN of routine clinical criteria
    Description
    PVN of the routine clinical criteria for identifying PLHIV not at-risk of disengagement from HIV care within 12 months
    Time Frame
    12 months
    Title
    Enhanced Adherence Counseling Session Attendance
    Description
    Proportion of enhanced adherence counseling sessions completed among sessions scheduled
    Time Frame
    6 months
    Title
    Viral Suppression with enhanced adherence counseling completion
    Description
    Proportion with HIV viral suppression after completion of enhanced adherence counseling sessions
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: PLHIV on ART who have had a viral load test with a valid result in the last 6 months; Age 18 years or older; Phone ownership OR consistent phone access; Not already enrolled in/currently attending enhanced adherence counseling sessions at the facility Living in Geita Region and intends to receive care at a study facility for the next 12 months; Classified as "high-risk" for loss to follow-up (LTFU) from HIV care, and Provides written informed consent for participation
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Sandra I McCoy, PhD, MPH
    Phone
    +15106420513
    Email
    smccoy@berkeley.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Sandra I McCoy, PhD, MPH
    Organizational Affiliation
    University of California, Berkeley
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Access Criteria
    Provided upon request

    Learn more about this trial

    Rudi Kundini, Pamoja Kundini

    We'll reach out to this number within 24 hrs